1
Return

Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept study

delete2026-07-01
delete0
delete
OA
AI
E
Emmanuelle Bardin
H
Hélène Salvator
C
Camille Roquencourt
E
Elodie Lamy
N
Nicolas Hunzinger
I
Isabelle Sermet‐Gaudelus
S
Sandra de Miranda
D
Dominique Grenet
P
Philippe Devillier
S
Stanislas Grassin‐Delyle *
DOI:10.1016/j.jcf.2026.06.013delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
• ETI induces rapid, measurable changes in exhaled volatile organic compounds. • Breath VOCs shift towards healthy levels within one week of ETI initiation. • Real-time PTR-MS enables non-invasive, point-of-care breath monitoring in CF. • Multilevel statistics identify monotonous and non-monotonous VOC trajectories. • Ten VOCs correlate with lung function and sweat chloride.tab.
Keywords:
Breathomics
Cystic fibrosis
CFTR modulators
Real-time mass spectrometry
Volatile organic compounds
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of Cystic Fibrosis cover
Journal of Cystic Fibrosis
IF:
6
Papers:
2.9K
Citations:
7.3K

Organization

U
H
Hôpital Foch
Scholars:
33
Papers: 27
Citations: 1.3K
I
Institut Necker Enfants Malades
Scholars:
54
Papers: 21
Citations: 2.0K
Cited Papers

Cited Papers

Citing Papers

Citing Papers